+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Life Science Analytics - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805616
The global market for Life Science Analytics was estimated at US$31.0 Billion in 2023 and is projected to reach US$74.6 Billion by 2030, growing at a CAGR of 13.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Life Science Analytics Market - Key Trends & Drivers Summarized

Why Is Life Science Analytics Becoming Integral to Healthcare and Research?

Life science analytics is becoming integral to healthcare and research as organizations increasingly rely on data-driven insights to improve patient outcomes, accelerate drug development, and enhance operational efficiency. By leveraging advanced analytics tools, such as artificial intelligence (AI) and machine learning, life science companies can analyze vast amounts of data from clinical trials, electronic health records, and genomics to uncover patterns and trends that inform decision-making. This data-driven approach is helping to personalize medicine, optimize clinical trials, and streamline research and development processes, making life science analytics a critical component in the modern healthcare ecosystem.

How Are Technological Advancements Shaping the Life Science Analytics Market?

Technological advancements are significantly enhancing the capabilities and applications of life science analytics. The integration of AI and machine learning algorithms into analytics platforms is enabling more sophisticated data analysis, allowing researchers and healthcare providers to identify insights that were previously difficult or impossible to detect. Cloud computing is also playing a key role by providing scalable and secure environments for storing and processing large datasets. Additionally, advancements in data visualization tools are making it easier for non-technical users to interpret complex data, leading to more informed decision-making across the life sciences industry. These technological innovations are driving the adoption of advanced analytics solutions, fueling growth in the life science analytics market.

What Are the Emerging Trends in the Life Science Analytics Market?

Several emerging trends are shaping the life science analytics market, including the increasing focus on personalized medicine, the growing use of real-world evidence in drug development, and the shift towards value-based care. Personalized medicine, which tailors treatments to individual patients based on their genetic makeup and other factors, is heavily reliant on advanced analytics to identify the most effective therapies. The use of real-world evidence, which involves analyzing data from sources such as electronic health records and patient registries, is also gaining traction as a way to support drug development and regulatory decision-making. Additionally, the shift towards value-based care, which emphasizes patient outcomes and cost-effectiveness, is driving the need for analytics solutions that can track and measure healthcare performance. These trends are contributing to the dynamic growth of the life science analytics market.

What Factors Are Driving the Growth of the Life Science Analytics Market?

The growth in the life science analytics market is driven by several factors, including the increasing adoption of advanced analytics tools in healthcare and research, the growing emphasis on personalized medicine, and the rising need for data-driven decision-making in the life sciences industry. The expansion of healthcare data, generated by electronic health records, clinical trials, and genomics, is a significant driver, as it creates a demand for powerful analytics solutions that can process and interpret this data. Additionally, the push towards value-based care and the use of real-world evidence in drug development are driving the adoption of analytics solutions. As the life sciences industry continues to evolve, the demand for advanced analytics is expected to grow, driving sustained growth in the market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Life Science Analytics Services segment, which is expected to reach US$44.7 Billion by 2030 with a CAGR of a 14.1%. The Life Science Analytics Software segment is also set to grow at 12.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $8.3 Billion in 2023, and China, forecasted to grow at an impressive 12.2% CAGR to reach $11.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Life Science Analytics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Life Science Analytics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Life Science Analytics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Accenture PLC, Cognizant Technology Solutions Corporation, IBM Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 44 Featured):

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • An Introduction to Life Science Analytics
  • Life Science Analytics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Relevance of Big Data Analytics to Improve Productivity in Life Science Industry
  • AI, ML & Big Data Transform Clinical Trials Market
  • Increasing Prevalence of Chronic Diseases Boosts Market Prospects
  • Need to Curb Surging Healthcare Spending & Improve Patient Outcomes Enhance Importance of Analytics
  • Growing Use of Analytics in Personalized and Precision Medicine: A Major Growth Opportunity
  • Global Precision Medicine Market Size (US$ Billion) for the Years 2019, 2022 and 2025
  • Growing Demand for Data-Driven Insights Spurs Growth in Life Science Analytics
  • Advancements in Big Data and AI Propel Adoption of Analytics in Life Sciences
  • Shift Towards Personalized Medicine Expands Addressable Market for Life Science Analytics
  • Rising Focus on Clinical Trials and Drug Development Drives Adoption of Advanced Analytics
  • Growing Application of Predictive Analytics in Patient Care Strengthens Market Demand
  • Technological Innovations in Cloud Computing Enhance Scalability and Accessibility of Analytics
  • Expanding Use of Real-World Data in Pharmaceutical Research Generates New Opportunities
  • Rising Importance of Analytics in Biomarker Discovery and Validation Strengthens Demand
  • Technological Advancements in Machine Learning and AI Algorithms Expand Market Potential
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Life Science Analytics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World 7-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Descriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Descriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World 7-Year Perspective for Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Prescriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 13: World 7-Year Perspective for Prescriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World 7-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: World 7-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 19: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World 7-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Research Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 23: World 7-Year Perspective for Research Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 24: World Recent Past, Current & Future Analysis for Third-Party Administrators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 25: World 7-Year Perspective for Third-Party Administrators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 28: USA Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 29: USA 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 30: USA Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 31: USA 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
CANADA
  • TABLE 34: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 35: Canada 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 36: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 37: Canada 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 40: Canada Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 41: Canada 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
JAPAN
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 42: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 43: Japan 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 46: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 47: Japan 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 48: Japan Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 49: Japan 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
CHINA
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 50: China Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 52: China Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 53: China 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 54: China Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 55: China 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: China 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
EUROPE
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 58: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 59: Europe 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 60: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 61: Europe 7-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Europe 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 64: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 65: Europe 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 66: Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 67: Europe 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
FRANCE
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 68: France Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: France 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 70: France Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 71: France 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 72: France Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 73: France 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 74: France Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: France 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
GERMANY
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 76: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 77: Germany 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 78: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 79: Germany 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Germany 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 82: Germany Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 83: Germany 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
ITALY
  • TABLE 84: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 85: Italy 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 86: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Italy 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 88: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 89: Italy 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 90: Italy Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 91: Italy 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
UNITED KINGDOM
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 92: UK Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: UK 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 94: UK Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 95: UK 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 96: UK Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 97: UK 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 98: UK Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: UK 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
REST OF EUROPE
  • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 101: Rest of Europe 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 103: Rest of Europe 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Rest of Europe 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 107: Rest of Europe 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
ASIA-PACIFIC
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 109: Asia-Pacific 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Asia-Pacific 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 113: Asia-Pacific 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 115: Asia-Pacific 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
REST OF WORLD
  • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Rest of World 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 119: Rest of World 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 121: Rest of World 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Rest of World 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

Table Information